Aarti Historical Income Statement

AARTIDRUGS

454.10 1.00 0.22%

Historical analysis of Aarti Drugs income statement accounts such as Interest Expense of 315 M, Selling General Administrative of 1.1 B or Selling And Marketing Expenses of 22.1 M can show how well Aarti Drugs Limited performed in making a profits. Evaluating Aarti Drugs income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Aarti Drugs's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Aarti Drugs Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aarti Drugs Limited is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Aarti Income Statement Analysis

Aarti Drugs Limited Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Aarti Drugs shareholders. The income statement also shows Aarti investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Aarti Drugs Income Statement Chart

At this time, Aarti Drugs' Selling General Administrative is relatively stable compared to the past year. As of 11/27/2024, Gross Profit is likely to grow to about 8.5 B, while Interest Expense is likely to drop slightly above 315 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Aarti Drugs Limited generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Aarti Drugs Limited minus its cost of goods sold. It is profit before Aarti Drugs operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Aarti Drugs' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Aarti Drugs Limited current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Interest Expense	207.5M	332.9M	378.9M	315.0M
Depreciation And Amortization	500.5M	503.2M	514.5M	367.1M

Interest Expense Depreciation And Amortization

Aarti Drugs income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Minority Interest	Reconciled Depreciation
Depreciation And Amortization		0.37	0.28	0.6	0.94	0.74	0.92	0.56	0.9	0.92	0.94	0.61	0.87	-0.24	0.86	0.91	0.77	0.76	0.78	-0.75	0.6	-0.24	0.73
Interest Expense	0.37		0.14	-0.14	0.18	0.17	0.17	0.12	0.08	0.12	0.17	0.11	-0.01	-0.33	-0.03	0.07	0.32	-0.2	-0.16	0.19	-0.4	-0.22	-0.08
Selling General Administrative	0.28	0.14		-0.45	0.33	0.73	0.23	0.93	0.24	0.24	0.28	0.0	0.23	-0.94	0.22	0.26	0.54	0.32	0.42	-0.45	0.17	-0.95	0.65
Selling And Marketing Expenses	0.6	-0.14	-0.45		0.62	0.24	0.71	-0.12	0.66	0.66	0.67	0.7	0.67	0.54	0.68	0.63	0.25	0.61	0.51	-0.48	0.63	0.47	0.37
Total Revenue	0.94	0.18	0.33	0.62		0.82	0.99	0.59	0.9	0.91	0.99	0.73	0.89	-0.24	0.88	0.9	0.79	0.82	0.82	-0.75	0.7	-0.3	0.82
Gross Profit	0.74	0.17	0.73	0.24	0.82		0.78	0.88	0.72	0.73	0.77	0.63	0.71	-0.63	0.7	0.73	0.74	0.74	0.79	-0.74	0.55	-0.73	0.92
Other Operating Expenses	0.92	0.17	0.23	0.71	0.99	0.78		0.5	0.87	0.89	0.99	0.8	0.86	-0.14	0.85	0.86	0.72	0.79	0.78	-0.73	0.69	-0.2	0.79
Operating Income	0.56	0.12	0.93	-0.12	0.59	0.88	0.5		0.56	0.57	0.55	0.2	0.56	-0.84	0.55	0.58	0.71	0.63	0.71	-0.71	0.45	-0.87	0.84
Ebit	0.9	0.08	0.24	0.66	0.9	0.72	0.87	0.56		1.0	0.9	0.56	1.0	-0.15	0.99	0.99	0.73	0.94	0.92	-0.83	0.82	-0.19	0.77
Ebitda	0.92	0.12	0.24	0.66	0.91	0.73	0.89	0.57	1.0		0.91	0.57	0.99	-0.16	0.99	0.99	0.75	0.93	0.92	-0.83	0.8	-0.2	0.77
Cost Of Revenue	0.94	0.17	0.28	0.67	0.99	0.77	0.99	0.55	0.9	0.91		0.7	0.88	-0.19	0.88	0.89	0.76	0.81	0.8	-0.77	0.72	-0.21	0.8
Total Operating Expenses	0.61	0.11	0.0	0.7	0.73	0.63	0.8	0.2	0.56	0.57	0.7		0.54	0.09	0.54	0.55	0.37	0.5	0.49	-0.38	0.39	-0.09	0.54
Income Before Tax	0.87	-0.01	0.23	0.67	0.89	0.71	0.86	0.56	1.0	0.99	0.88	0.54		-0.13	1.0	0.98	0.71	0.97	0.94	-0.85	0.86	-0.18	0.78
Total Other Income Expense Net	-0.24	-0.33	-0.94	0.54	-0.24	-0.63	-0.14	-0.84	-0.15	-0.16	-0.19	0.09	-0.13		-0.11	-0.17	-0.45	-0.18	-0.27	0.28	-0.03	0.92	-0.5
Net Income	0.86	-0.03	0.22	0.68	0.88	0.7	0.85	0.55	0.99	0.99	0.88	0.54	1.0	-0.11		0.97	0.7	0.97	0.94	-0.84	0.87	-0.17	0.78
Income Tax Expense	0.91	0.07	0.26	0.63	0.9	0.73	0.86	0.58	0.99	0.99	0.89	0.55	0.98	-0.17	0.97		0.73	0.93	0.94	-0.84	0.8	-0.22	0.75
Research Development	0.77	0.32	0.54	0.25	0.79	0.74	0.72	0.71	0.73	0.75	0.76	0.37	0.71	-0.45	0.7	0.73		0.66	0.68	-0.56	0.4	-0.54	0.76
Net Income From Continuing Ops	0.76	-0.2	0.32	0.61	0.82	0.74	0.79	0.63	0.94	0.93	0.81	0.5	0.97	-0.18	0.97	0.93	0.66		0.97	-0.89	0.9	-0.26	0.85
Tax Provision	0.78	-0.16	0.42	0.51	0.82	0.79	0.78	0.71	0.92	0.92	0.8	0.49	0.94	-0.27	0.94	0.94	0.68	0.97		-0.91	0.85	-0.37	0.85
Interest Income	-0.75	0.19	-0.45	-0.48	-0.75	-0.74	-0.73	-0.71	-0.83	-0.83	-0.77	-0.38	-0.85	0.28	-0.84	-0.84	-0.56	-0.89	-0.91		-0.86	0.3	-0.85
Net Interest Income	0.6	-0.4	0.17	0.63	0.7	0.55	0.69	0.45	0.82	0.8	0.72	0.39	0.86	-0.03	0.87	0.8	0.4	0.9	0.85	-0.86		-0.03	0.7
Minority Interest	-0.24	-0.22	-0.95	0.47	-0.3	-0.73	-0.2	-0.87	-0.19	-0.2	-0.21	-0.09	-0.18	0.92	-0.17	-0.22	-0.54	-0.26	-0.37	0.3	-0.03		-0.58
Reconciled Depreciation	0.73	-0.08	0.65	0.37	0.82	0.92	0.79	0.84	0.77	0.77	0.8	0.54	0.78	-0.5	0.78	0.75	0.76	0.85	0.85	-0.85	0.7	-0.58

Click cells to compare fundamentals

Aarti Drugs Account Relationship Matchups

Aarti Drugs income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	487.5M	498.8M	500.5M	503.2M	514.5M	367.1M
Interest Expense	337.3M	229.6M	207.5M	332.9M	378.9M	315.0M
Selling General Administrative	80.8M	94.4M	132.3M	133.7M	1.0B	1.1B
Selling And Marketing Expenses	545.3M	650.2M	683.6M	702.8M	23.3M	22.1M
Total Revenue	18.1B	21.5B	24.9B	27.2B	25.1B	13.6B
Gross Profit	4.0B	6.0B	5.0B	8.3B	8.1B	8.5B
Other Operating Expenses	15.8B	17.6B	21.9B	24.6B	18.1B	11.7B
Operating Income	2.1B	3.9B	2.9B	2.6B	7.1B	7.5B
Ebit	2.2B	4.0B	2.9B	2.6B	2.7B	1.7B
Ebitda	2.7B	4.5B	3.4B	3.1B	3.2B	2.0B
Cost Of Revenue	14.0B	15.5B	19.8B	18.9B	17.0B	10.3B
Total Operating Expenses	1.8B	2.1B	2.1B	5.7B	1.2B	1.4B
Income Before Tax	1.9B	3.7B	2.7B	2.2B	2.4B	1.3B
Total Other Income Expense Net	(377.1M)	(251.3M)	(171.6M)	(406.4M)	(4.8B)	(4.6B)
Net Income	1.4B	2.8B	2.1B	1.7B	1.7B	969.9M
Income Tax Expense	438.9M	886.2M	649.6M	578.2M	639.4M	358.6M
Research Development	87.4M	86.0M	66.1M	77.5M	120.2M	70.5M
Net Income From Continuing Ops	1.4B	2.8B	2.1B	1.7B	1.7B	1.4B
Net Income Applicable To Common Shares	1.4B	2.8B	2.1B	1.7B	1.9B	1.4B
Tax Provision	438.9M	886.2M	649.6M	578.2M	639.4M	566.4M
Interest Income	305.7M	229.6M	207.5M	332.9M	299.6M	256.1M
Net Interest Income	(363.0M)	(229.6M)	(207.5M)	(332.9M)	(335.2M)	(352.0M)
Reconciled Depreciation	487.5M	498.8M	500.5M	503.2M	514.5M	523.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Aarti Stock Analysis

When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aarti Historical Income Statement

About Aarti Income Statement Analysis

Aarti Drugs Income Statement Chart

Total Revenue

Gross Profit

Aarti Drugs income statement Correlations

Aarti Drugs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aarti Drugs income statement Accounts

Also Currently Popular

Additional Tools for Aarti Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Other Operating Expenses	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Other Operating Expenses

Minority Interest	- 0.95	Selling General Administrative
Total Other Income Expense Net	- 0.94	Selling General Administrative
Interest Income	- 0.91	Tax Provision
Interest Income	- 0.89	Net Income From Continuing Ops
Minority Interest	- 0.87	Operating Income
Net Interest Income	- 0.86	Interest Income